Literature DB >> 10330042

Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury.

R H Watkins1, C T D'Angio, R M Ryan, A Patel, W M Maniscalco.   

Abstract

Lung development and repair of hyperoxic injury require closely regulated growth and regeneration of alveolar capillaries. Vascular endothelial growth factor (VEGF), a mitogen for endothelial cells, is expressed by alveolar epithelial cells. Alternative splicing of VEGF mRNA results in isoforms of varying mitogenicity and solubility. We examined changes in the proportions of the VEGF splice variant mRNAs in rabbit lung development and in control, oxygen-injured, and recovering newborn and adult rabbit lungs. The proportion of the 189-amino acid VEGF mRNA, which codes for an isoform that binds to the extracellular matrix, increased fivefold during development (from 8% of total VEGF message at 22 days gestation to 40% in 10-day newborn lungs; P < 0.001). During neonatal oxygen injury, its expression declined from 38 to 8% of VEGF message (P < 0.002) and returned to the control value in recovery. A similar pattern was observed in adults. VEGF protein in lung lavage fluid increased slightly during hyperoxia, declined to barely detectable levels at the 50% lethal dose time point, and increased 10-fold (newborn) or up to 40-fold (adult) in recovering animals. We conclude that alternative splicing may have important roles in the regulation of VEGF activity in developing and injured lungs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10330042     DOI: 10.1152/ajplung.1999.276.5.L858

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury.

Authors:  J Corne; G Chupp; C G Lee; R J Homer; Z Zhu; Q Chen; B Ma; Y Du; F Roux; J McArdle; A B Waxman; J A Elias
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

Review 3.  VEGF levels in humans and animal models with RDS and BPD: temporal relationships.

Authors:  Stephanie Meller; Vineet Bhandari
Journal:  Exp Lung Res       Date:  2012-03-06       Impact factor: 2.459

4.  Endothelial cell activation in a VEGF-A gradient: relevance to cell fate decisions.

Authors:  Ann Akeson; Amanda Herman; Diane Wiginton; James Greenberg
Journal:  Microvasc Res       Date:  2010-02-06       Impact factor: 3.514

Review 5.  The role of hyperoxia in the pathogenesis of experimental BPD.

Authors:  Bradley W Buczynski; Echezona T Maduekwe; Michael A O'Reilly
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

6.  Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.

Authors:  Xiao-Feng Liao; Ji-Lin Yi; Xing-Rui Li; Wei Deng; Zhi-Fang Yang; Geng Tian
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

7.  Hyperoxia enhances VEGF release from A549 cells via post-transcriptional processes.

Authors:  Jeffrey S Shenberger; Lianqin Zhang; Richard J Powell; Aaron Barchowsky
Journal:  Free Radic Biol Med       Date:  2007-06-06       Impact factor: 7.376

8.  VEGF189 expression is highly related to adaptation of the plateau pika (Ochotona curzoniae) inhabiting high altitudes.

Authors:  Hongge Li; Songchang Guo; Yongming Ren; Depeng Wang; Honghao Yu; Wenjing Li; Xinquan Zhao; Zhijie Chang
Journal:  High Alt Med Biol       Date:  2013-12       Impact factor: 1.981

9.  Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia.

Authors:  Hyeon-Soo Lee; Chun-Ki Kim
Journal:  Respir Res       Date:  2011-05-24

10.  The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing.

Authors:  John B Christoforidis; Jillian Wang; Angela Jiang; James Willard; Cedric Pratt; Mahmoud Abdel-Rasoul; Sashwati Roy; Heather Powell
Journal:  Clin Ophthalmol       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.